Ausgabe 6/2015
Inhalt (19 Artikel)
Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma
Lizhu Jiang, Xiaosong Wu, Peng Wang, Taoyu Wen, Chao Yu, Lei Wei, Hongyan Chen
The chemokine CXCL9 exacerbates chemotherapy-induced acute intestinal damage through inhibition of mucosal restitution
Huili Lu, Hongyu Liu, Jiaxian Wang, Jiaqing Shen, Shunyan Weng, Lei Han, Tao Sun, Lan Qian, Mingyuan Wu, Shunying Zhu, Yan Yu, Wei Han, Jianwei Zhu, Anja Moldenhauer
Identification of FLOT2 as a novel target for microRNA-34a in melanoma
Rui Liu, Huiqing Xie, Chengqun Luo, Zizi Chen, Xiao Zhou, Kun Xia, Xiang Chen, Ming Zhou, Peiguo Cao, Ke Cao, Jianda Zhou
Influence of tumor volume on survival in patients with oral squamous cell carcinoma
Thomas Mücke, David A. Mitchell, Lucas M. Ritschl, Andrea Tannapfel, Klaus-Dietrich Wolff, Marco R. Kesting, Denys J. Loeffelbein, Anastasios Kanatas
BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation
Lin Wang, Paul Park, Frank La Marca, Khoi D. Than, Chia-Ying Lin
The combined use of Camellia sinensis and metronomic zoledronic acid in a breast cancer-induced osteolysis mouse model
Ke-Wang Luo, Chun-Hay Ko, Grace Gar-Lee Yue, Si Gao, Julia Kin-Ming Lee, Gang Li, Kwok-Pui Fung, Ping-Chung Leung, Andreas Evdokiou, Clara Bik-San Lau
NAIF1 inhibits gastric cancer cells migration and invasion via the MAPK pathways
Mei Yang, Yu-yu Gu, Hua Peng, Mei Zhao, Jia Wang, Sheng-kai Huang, Xing-hua Yuan, Jia Li, Jian-li Sang, Qing Luo, Changzhi Huang
In vitro effects and ex vivo binding of an EGFR-specific immunotoxin on rhabdomyosarcoma cells
Judith Niesen, Hannes Brehm, Christoph Stein, Nina Berges, Alessa Pardo, Rainer Fischer, Andre ten Haaf, Stefan Gattenlöhner, Mehmet K. Tur, Stefan Barth
High dose versus conventional dose in external beam radiotherapy of prostate cancer: a meta-analysis of long-term follow-up
Zan Hou, Guangjun Li, Sen Bai
Current status of chemotherapy use and clinical outcome in octogenarians with advanced non-small cell lung cancer
Sung Hoon Sim, Yu Jung Kim, Se Hyun Kim, Bhumsuk Keam, Tae Min Kim, Se-Hoon Lee, Dong-Wan Kim, Dae Seog Heo, Jong Seok Lee
Post-operative nomogram for predicting freedom from recurrence after surgery in localised breast cancer receiving adjuvant hormone therapy
Chafika Mazouni, Frédéric Fina, Sylvie Romain, Pascal Bonnier, L’houcine Ouafik, Pierre-Marie Martin
Superior outcome using cyclosporin A alone versus cyclosporin A plus methotrexate for post-transplant immunosuppression in children with acute leukemia undergoing sibling hematopoietic stem cell transplantation
Melissa Weiss, Daniel Steinbach, Felix Zintl, James Beck, Bernd Gruhn
Polymorphisms of monocarboxylate transporter genes are associated with clinical outcomes in patients with colorectal cancer
Fei Fei, Xu Guo, Yibing Chen, Xiaonan Liu, Jianfei Tu, Jinliang Xing, Zhinan Chen, Jiansong Ji, Xianli He
Arsenic trioxide transarterial chemoembolization with and without additional intravenous administration of arsenic trioxide in unresectable hepatocellular carcinoma with lung metastasis: a single-blind, randomized trial
Bing Liu, Jian-wen Huang, Yong Li, Bao-shan Hu, Xu He, Wei Zhao, You-bing Zheng, Li-gong Lu
Convergence with SEER database achieved by a breast cancer network: a longitudinal benchmark of 5-year relative survival
Christian O. Jacke, Ute S. Albert, Iris Reinhard, Matthias Kalder
Differential diagnosis between metastatic and non-metastatic lymph nodes using DW-MRI: a meta-analysis of diagnostic accuracy studies
Min Zhou, Bin Lu, Gang Lv, Qin Tang, Jibiao Zhu, Jun Li, Kaide Shi
Charlson comorbidity index: an additional prognostic parameter for preoperative glioblastoma patient stratification
G. Ening, F. Osterheld, D. Capper, K. Schmieder, C. Brenke
Regarding Ening et al. Charlson comorbidity index: an additional prognostic parameter for preoperative glioblastoma patient stratification
Alba Fiorentino, Francesco Ricchetti, Rosario Mazzola, Sergio Fersino, Niccolò Giaj Levra, Filippo Alongi